COVID-19 Monoclonal Antibody Therapeutics
Please see the flyers regarding two Johns Hopkins outpatient convalescent plasma trials that may be of interest. One trial is for post-exposure prophylaxis (i.e., high-risk exposure), while the other is for mild infection.
Communicable Disease Surveillance Data: https://www.vdh.virginia.gov/surveillance-and-investigation/virginia-reportable-disease-surveillance-data/
Online Disease Reporting Portal: https://www.vdh.virginia.gov/surveillance-and-investigation/commonwealth-of-virginiastate-board-of-health/
Healthcare-Associated Infections and Antimicrobial Resistance: https://www.vdh.virginia.gov/haiar/
Rabies Post-Exposure Prophylaxis Toolkit for Providers: https://vhost45.sitevision.com/courses/OEPI/Rabies/index.html
Personal Protective Equipment (PPE)
2018 PWHD Communicable Disease Report
Chronic Pain Training Plan Now Available on TRAIN
Opioid abuse has increasingly become a serious public health issue over the past few years, with over 12 million people misusing prescription opioids in 2015. Providers’ Clinical Support System for Opioid Therapies (PCSS-O) clinical experts, led by Roger Chou and Melissa B. Weimer, who have extensive knowledge in treating chronic pain, have developed a comprehensive core curriculum for primary care providers who want to have in-depth knowledge in this subject area. The curriculum gives up-to-date and evidence-based information on best opioid prescribing practices.
The PCSS-O curriculum, which provides clinicians with a solid base for treating chronic pain, is now on TRAIN as a nationally available training plan. It is the most comprehensive and up-to-date curriculum developed thus far for the treatment of chronic pain.
Funding for this initiative was made possible (in part) by grant no. 5H79TI025595-03 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.